# Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy

> **NCT07201519** · PHASE2 · RECRUITING · sponsor: **Michael J Cavnar, MD** · enrollment: 80 (estimated)

## Conditions studied

- Colorectal Cancer Metastatic
- Intrahepatic Cholangiocarcinoma

## Interventions

- **DEVICE:** Hepatic Artery Infusion Pump (HAIP)
- **PROCEDURE:** Standard Treatment
- **PROCEDURE:** Community Treatment
- **DRUG:** Systemic Chemotherapy Standard of Care
- **DRUG:** Standard Of Care targeting driver mutations

## Key facts

- **NCT ID:** NCT07201519
- **Lead sponsor:** Michael J Cavnar, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-23
- **Primary completion:** 2028-02
- **Final completion:** 2030-02
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07201519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07201519, "Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07201519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*